How is Prostate cancer diagnosed?

Teerera peji iri

Kenza yeprostate inoonekwa sei?

Kenza yeprostate inoonekwa kupfurikidza nokubatanidza miedzo nemitoo, iyo ingasanganisira:

1. Digital Rectal Exam (DRE): Chiremba anopinza munwe une magirovhosi, wakanyoroveswa mu rectum kuti anzwe prostate nokuda kwezvikanganiso chipi nechipi.

2. Prostate-Specific Antigen (PSA) Test: Uku kuongorora ropa kunoyera mwero wePSA, mapuroteni anogadzirwa neprostate gland.

Nhamba dzakakwirira dzePSA dzinogona kuratidza kuvapo kwekenza yeprostate.

3. Transrectal Ultrasound (TRUS): Chiongorori chiduku chinopinzwa mu rectum kuti chigadzire mufananidzo weprostate uchishandisa masaisai enzwi.

Ikoku kunogona kubetsera kuziva kusagadzikana kupi nokupi mu prostate gland.

4. Biopsy: Muenzaniso muduku wetsandanyama yeprostate unobviswa ndokuongororwa pasi pemicroscope nokuda kwokuvapo kwemasero ekenza.

Iyi ndiyo nzira bedzi yechokwadi yokuongorora nayo kenza yeprostate.

5. Magnetic Resonance Imaging (MRI): MRI scan yeprostate inogona kubetsera kuziva kusarongeka kupi nokupi uye kutungamirira muitiro webiopsy.

6. Genomic Testing: Vamwe vanachiremba vangashandisa genomic tests kuti vabatsire kuona kuti kenza yacho ine utsinye zvakadini uye kuti vatungamirire zvisarudzo zvokurapa.

7. Bone Scan: Bone scan inogona kuitwa kuti uone kana kenza yapararira kumapfupa.

8. Computed Tomography (CT) Scan: CT scan inogona kushandiswa kuongorora kana kenza yapararira kune dzimwe nhengo kana kuti tishu.

Zvinokosha kucherechedza kuti havasi varume vose vane mwero wePSA wakakwira kana kuti migumisiro isina kujairika yeDRE vachava nekenza yeprostate, uye havasi kenza yose yeprostate ichakonzera mwero wePSA wakakwira.

Naizvozvo, biopsy inodikanwa kusimbisa chirwere chacho.

Mukuwedzera, chisarudzo chokuitwa biopsy chinoitwa pashure pokurangarira migumisiro yokuongororwa uku nezvinhu zvinokuvadza munhu wacho nezvaanoda.

Mashoko okufananidzira

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Saldova R, Fan Y, Fitzpatrick JM, Watson RW, Rudd PM: Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology. 2011, 21 (2): 195-205.

Marenco J, Kasivisvanathan V, Emberton M: New standards in prostate biopsy. Arch Esp Urol. 2019, 72 (2): 142-149.

Moradi M, Mousavi P, Abolmaesumi P: Computer-aided diagnosis of prostate cancer with emphasis on ultrasound-based approaches: a review. Ultrasound Med Biol. 2007, 33 (7): 1010-28.

Cuperlovic-Culf M, Belacel N, Davey M, Ouellette RJ: Multi-gene biomarker panel for reference free prostate cancer diagnosis: determination and independent validation. Biomarkers. 2010, 15 (8): 693-706.

McGrath SE, Michael A, Morgan R, Pandha H: EN2: a novel prostate cancer biomarker. Biomark Med. 2013, 7 (6): 893-901.

An Y, Chang W, Wang W, Wu H, Pu K, Wu A, Qin Z, Tao Y, Yue Z, Wang P, Wang Z: A novel tetrapeptide fluorescence sensor for early diagnosis of prostate cancer based on imaging Zn2+ in healthy versus cancerous cells. J Adv Res. 2020, 24 (): 363-370.

[Consensus of Chinese experts on the application of molecular imaging targeting prostate specific membrane antigen in prostate cancer patients]. Zhonghua Wai Ke Za Zhi. 2018, 56 (2): 91-94.

Zhong WD, He HC, Bi XC, Ou RB, Jiang SA, Liu LS: cDNA macroarray for analysis of gene expression profiles in prostate cancer. Chin Med J (Engl). 2006, 119 (7): 570-3.

Kurambidzwa kwebasa: zvokurapa

Nzvimbo iyi yepaIndaneti inopiwa nokuda kwezvinangwa zvedzidzo uye zvemashoko chete uye haisi kupa mazano ezvokurapa kana kuti mabasa ehunyanzvi.

Mashoko anopiwa haafaniri kushandiswa kuongorora kana kuti kurapa chinetso cheutano kana kuti chirwere, uye avo vanotsvaka mazano ezvokurapa vanofanira kubvunza chiremba ane rezinesi.

Ndapota cherechedzai kuti neural net iyo inogadzira mhinduro dzemibvunzo, haina kururama zvikuru kana iri nyaya yenhamba. Somuenzaniso, nhamba yevanhu vanoonekwa vaine chirwere chakati.

Nguva dzose tsvaka zano rachiremba wako kana mumwe mupi wezvoutano akakodzera pamusoro pemamiriro ezvinhu ezvokurapa. Usambofa wakaregeredza zano rezvokurapa rehunyanzvi kana kunonoka kuritsvaka nemhaka yechinhu chipi nechipi chawakaverenga pawebsite ino. Kana uchifunga kuti unogona kuva nenjodzi yezvokurapa, fonera 911 kana kuenda kukamuri rokukurumidzira riri pedyo nokukurumidza. Hapana ukama hwechiremba nemurwere hunogadzirwa newebhusaiti ino kana kushandiswa kwayo. NeBioMedLib kana vashandi vayo, kana chero mupiro kune iyi webhusaiti, haitauri chero zvirevo, zvakataurwa kana kuti zvataurwa, maererano neruzivo rwunopihwa pano kana kushandiswa kwayo.

Kurega mutoro: kodzero dzekunyora

Digital Millennium Copyright Act ya1998, 17 U.S.C. § 512 (iyo DMCA) inopa nzira yekutsvaga varidzi vemvumo vanotenda kuti zvinhu zvinoonekwa paInternet zvinotyora kodzero dzavo pasi pemutemo wekodzero dzeUS.

Kana iwe uchidavira mukutenda kwakanaka kuti chero zvemukati kana zvinhu zvakaitwa kuti zviwanikwe zvine chekuita newebhusaiti yedu kana masevhisi zvinotyora kodzero dzako, iwe (kana mumiririri wako) unogona kutitumira chiziviso chinokumbira kuti zvemukati kana zvinhu zvibviswe, kana kuwana kwazviri kuvharirwa.

Zviziviso zvinofanira kutumirwa zvakanyorwa neemail (ona chikamu che"Kubata" kuti uwane kero yeemail).

DMCA inoda kuti chiziviso chako chekutyora kwekodzero dzekodzero dzekodzero zvinosanganisira ruzivo runotevera: (1) tsananguro yebasa rine kodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero dzekodzero.

(5) chirevo chako, chakasainwa pasi pechirango chehupombwe, chokuti mashoko ari mukuziviswa ndeechokwadi uye kuti une simba rokumanikidza kodzero dzevanyori dzinonzi dzakaputsika;

uye (6) siginicha yepanyama kana yemagetsi yemuridzi wekodzero kana munhu ane mvumo yekuita muzita remuridzi wekodzero.

Kukundikana kuisa mashoko ose ari pamusoro apa kungaguma nokunonoka kugadziriswa kwekunyunyuta kwako.

Kutaurirana

Ndapota titumirei email nemibvunzo ipi neipi / mazano.

How is prostate cancer diagnosed?

Prostate cancer is diagnosed through a combination of tests and procedures, which may include:

1. Digital Rectal Exam (DRE): A doctor inserts a gloved, lubricated finger into the rectum to feel the prostate for any abnormalities.

2. Prostate-Specific Antigen (PSA) Test: This is a blood test that measures the level of PSA, a protein produced by the prostate gland.

Elevated PSA levels may indicate the presence of prostate cancer.

3. Transrectal Ultrasound (TRUS): A small probe is inserted into the rectum to create an image of the prostate using sound waves.

This can help identify any abnormalities in the prostate gland.

4. Biopsy: A small sample of prostate tissue is removed and examined under a microscope for the presence of cancer cells.

This is the only definitive way to diagnose prostate cancer.

5. Magnetic Resonance Imaging (MRI): An MRI scan of the prostate can help identify any abnormalities and guide the biopsy procedure.

6. Genomic Testing: Some doctors may use genomic tests to help determine the aggressiveness of the cancer and guide treatment decisions.

7. Bone Scan: A bone scan may be performed to check if the cancer has spread to the bones.

8. Computed Tomography (CT) Scan: A CT scan may be used to check if the cancer has spread to other organs or tissues.

It is important to note that not all men with elevated PSA levels or abnormal DRE results will have prostate cancer, and not all prostate cancers will cause elevated PSA levels.

Therefore, a biopsy is necessary to confirm the diagnosis.

Additionally, the decision to undergo a biopsy is made after considering the results of these tests and the individual's risk factors and preferences.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.